Key result
Cardiomyocyte-specific overexpression of iNOS in transgenic mice significantly increased mortality due to progressive heart block and sudden cardiac death.
Why the study?
Does cardiomyocyte overexpression of iNOS cause cardiomyopathy, bradyarrhythmia, and sudden cardiac death in a transgenic mouse model?
Does cardiomyocyte overexpression of iNOS cause cardiomyopathy, bradyarrhythmia, and sudden cardiac death in a transgenic mouse model?
Cardiomyocyte-specific overexpression of iNOS in mice is sufficient to cause peroxynitrite generation, cardiomyopathy, progressive heart block, and sudden cardiac death.
Answers are grounded in this paper and cite their sources.
iNOS overexpression may cause heart block and SCD in mice; leaves open whether iNOS inhibition benefits human cardiomyopathy.
Increased inducible nitric oxide synthase (iNOS) expression is a component of the immune response and has been demonstrated in cardiomyocytes in septic shock, myocarditis, transplant rejection, ischemia, and dilated cardiomyopathy. To explore whether the consequences of such expression are adaptive or pathogenic, we have generated a transgenic mouse model conditionally targeting the expression of a human iNOS cDNA to myocardium. Chronic cardiac-specific upregulation of iNOS in transgenic mice led to increased production of peroxynitrite. This was associated with a mild inflammatory cell infiltrate, cardiac fibrosis, hypertrophy, and dilatation. While iNOS-overexpressing mice infrequently developed overt heart failure, they displayed a high incidence of sudden cardiac death due to bradyarrhythmia. This dramatic cardiac phenotype was rescued by specific attenuation of transgene activity. These data implicate cardiomyocyte iNOS overexpression as sufficient to cause cardiomyopathy, bradyarrhythmia, and sudden cardiac death.
No takes yet. Share an insight, caveat, or question.
Mungrue et al. (2002) studied Cardiomyopathy and sudden cardiac death. Cardiomyocyte overexpression of iNOS vs. DOX-treated mice or nonbinary littermates was evaluated on Mortality (p=<0.0001). Cardiomyocyte-specific overexpression of iNOS in transgenic mice significantly increased mortality due to progressive heart block and sudden cardiac death.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: